NCT03229278
- Conditions
- Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +73 more
- Locations
-
- Rutgers Cancer Institute of New Jersey New Brunswick, New Jersey, United States
Clinical trial condition
Recurrent Renal Cell Carcinoma
Explore clinical trials studying Recurrent Renal Cell Carcinoma. Study availability and eligibility vary by location and protocol.
30 public trials
1 recruiting study
Recurrent Renal Cell Carcinoma trial results
NCT01061411
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +17 more
- Locations
-
- City of Hope Comprehensive Cancer Center Duarte, California, United States
- Roswell Park Cancer Institute Buffalo, New York, United States
- Academ Zienkenhuis Bij De University Amsterdam, Netherlands
- VU University Medical Center Amsterdam, Netherlands
NCT02035358
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +24 more
- Locations
-
- University of Iowa Hospitals and Clinics Iowa City, Iowa, United States
- John Hopkins University Baltimore, Maryland, United States
- Univeristy of Utah Salt Lake City, Utah, United States
NCT00121251
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +16 more
- Locations
-
- Laura and Isaac Perlmutter Cancer Center at NYU Langone New York, United States
- Mount Sinai Hospital New York, United States
- Weill Medical College of Cornell University New York, United States
- Montefiore Medical Center - Moses Campus The Bronx, New York, United States
Completed
Nanoparticle Albumin-Bound Rapamycin in Treating Patients With Advanced Cancer With mTOR Mutations
NCT02646319
- Conditions
- Adenocarcinoma, Adnexal Diseases, Advanced Malignant Neoplasm, +73 more
- Locations
-
- Mayo Clinic in Arizona Scottsdale, Arizona, United States
- Mayo Clinic Rochester, Minnesota, United States
NCT01688973
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +18 more
- Locations
-
- University of Arizona Cancer Center-Orange Grove Campus Tucson, Arizona, United States
- University of Arizona Cancer Center-North Campus Tucson, Arizona, United States
- The University of Arizona Medical Center-University Campus Tucson, Arizona, United States
- Kaiser Permanente-Anaheim Anaheim, California, United States
Completed
Bevacizumab, Sorafenib Tosylate, and Temsirolimus in Treating Patients With Metastatic Kidney Cancer
NCT00378703
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +16 more
- Locations
-
- University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
- Providence Hospital Mobile, Alabama, United States
- Mayo Clinic in Arizona Scottsdale, Arizona, United States
- The University of Arizona Medical Center-University Campus Tucson, Arizona, United States
NCT01727089
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +18 more
- Locations
-
- City of Hope Comprehensive Cancer Center Duarte, California, United States
- USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
- University of California Davis Comprehensive Cancer Center Sacramento, California, United States
- City of Hope South Pasadena South Pasadena, California, United States
NCT00278395
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +15 more
- Locations
-
- Cancer Therapy and Research Center at The UT Health Science Center at San Antonio San Antonio, Texas, United States
- Institute for Drug Development San Antonio, Texas, United States
NCT00499135
- Conditions
- Adenocarcinoma, Adult Solid Neoplasm, Carcinoma, +18 more
- Locations
-
- University of Wisconsin Hospital and Clinics Madison, Wisconsin, United States